Superior Vena Cava Syndrome: Etiologies, Manifestations, and Treatments

Keith B. Quencer

doi:10.1055/s-0042-1753480

Seminars in Interventional Radiology, Table of Contents

Semin intervent Radiol 2022; 39(03): 292-303
DOI: 10.1055/s-0042-1753480

Review Article

Superior Vena Cava Syndrome: Etiologies, Manifestations, and Treatments

Authors

Keith B. Quencer

¹Dotter Interventional Institute, Oregon Health and Science University, Portland, Oregon

Abstract

Superior vena cava (SVC) obstruction, whether from benign or malignant causes, results in a variety of symptoms. It is a potential medical emergency when cerebral or laryngeal edema occurs. Endovascular therapy is the treatment of choice for patients in need of emergent relief of symptoms. This article will provide a review of SVC syndrome with a focus on endovascular treatment techniques.

Keywords

SVC syndrome - SVC stenting - stent migration - pericardial tamponade - interventional radiology

Full Text

References

References
1 Büstgens FA, Loose R, Ficker JH, Wucherer M, Uder M, Adamus R. Stent implantation for superior vena cava syndrome of malignant cause. Röfo Fortschr Geb Röntgenstr Nuklearmed 2017; 189 (05) 423-430
2 Rice TW, Rodriguez RM, Light RW. The superior vena cava syndrome: clinical characteristics and evolving etiology. Medicine (Baltimore) 2006; 85 (01) 37-42
3 Rowell NP, Gleeson FV. Steroids, radiotherapy, chemotherapy and stents for superior vena caval obstruction in carcinoma of the bronchus. Cochrane Database Syst Rev 2001; (04) CD001316
4 Wan JF, Bezjak A. Superior vena cava syndrome. Hematol Oncol Clin North Am 2010; 24 (03) 501-513
5 Dela Cruz CS, Tanoue LT, Matthay RA. Lung cancer: epidemiology, etiology, and prevention. Clin Chest Med 2011; 32 (04) 605-644
6 Picquet J, Blin V, Dussaussoy C, Jousset Y, Papon X, Enon B. Surgical reconstruction of the superior vena cava system: indications and results. Surgery 2009; 145 (01) 93-99
7 Schifferdecker B, Shaw JA, Piemonte TC, Eisenhauer AC. Nonmalignant superior vena cava syndrome: pathophysiology and management. Catheter Cardiovasc Interv 2005; 65 (03) 416-423
8 Caers J, Fontaine C, Vinh-Hung V. et al. Catheter tip position as a risk factor for thrombosis associated with the use of subcutaneous infusion ports. Support Care Cancer 2005; 13 (05) 325-331
9 Seo M, Shin WJ, Jun IG. Central venous catheter-related superior vena cava syndrome following renal transplantation - a case report. Korean J Anesthesiol 2012; 63 (06) 550-554
10 Deshwal H, Ghosh S, Magruder K, Bartholomew JR, Montgomery J, Mehta AC. A review of endovascular stenting for superior vena cava syndrome in fibrosing mediastinitis. Vasc Med 2020; 25 (02) 174-183
11 McIntire FT, Sykes Jr EM. Obstruction of the superior vena cava; a review of the literature and report of two personal cases. Ann Intern Med 1949; 30 (05) 925-960
12 Bayer O, Schummer C, Richter K, Fröber R, Schummer W. Implication of the anatomy of the pericardial reflection on positioning of central venous catheters. J Cardiothorac Vasc Anesth 2006; 20 (06) 777-780
13 Kim HJ, Kim HS, Chung SH. CT diagnosis of superior vena cava syndrome: importance of collateral vessels. AJR Am J Roentgenol 1993; 161 (03) 539-542
14 Stanford W, Jolles H, Ell S, Chiu LC. Superior vena cava obstruction: a venographic classification. AJR Am J Roentgenol 1987; 148 (02) 259-262
15 Eren S, Karaman A, Okur A. The superior vena cava syndrome caused by malignant disease. Imaging with multi-detector row CT. Eur J Radiol 2006; 59 (01) 93-103
16 Hussein FA, Mawla N, Befeler AS, Martin KJ, Lentine KL. Formation of downhill esophageal varices as a rare but serious complication of hemodialysis access: a case report and comprehensive literature review. Clin Exp Nephrol 2008; 12 (05) 407-415
17 Loudin M, Anderson S, Schlansky B. Bleeding ‘downhill’ esophageal varices associated with benign superior vena cava obstruction: case report and literature review. BMC Gastroenterol 2016; 16 (01) 134
18 Felson B, Lessure AP. “Downhill” varices of the esophagus. Dis Chest 1964; 46: 740-746
19 Uceda PV, Peralta Rodriguez J, Vela H. et al. Management of superior vena cava occlusion causing bleeding “downhill” esophageal varices. J Endovasc Ther 2021; 28 (03) 469-473
20 Aloufi FF, Alabdulkarim FM, Alshahrani MA. The focal hepatic hot spot (“hot quadrate”) sign. Abdom Radiol (NY) 2017; 42 (04) 1289-1290
21 Ahmann FR. A reassessment of the clinical implications of the superior vena caval syndrome. J Clin Oncol 1984; 2 (08) 961-969
22 Yu JB, Wilson LD, Detterbeck FC. Superior vena cava syndrome – a proposed classification system and algorithm for management. J Thorac Oncol 2008; 3 (08) 811-814
23 Gauden SJ. Superior vena cava syndrome induced by bronchogenic carcinoma: is this an oncological emergency?. Australas Radiol 1993; 37 (04) 363-366
24 Furui S, Sawada S, Kuramoto K. et al. Gianturco stent placement in malignant caval obstruction: analysis of factors for predicting the outcome. Radiology 1995; 195 (01) 147-152
25 Nicholson AA, Ettles DF, Arnold A, Greenstone M, Dyet JF. Treatment of malignant superior vena cava obstruction: metal stents or radiation therapy. J Vasc Interv Radiol 1997; 8 (05) 781-788
26 Rowell NP, Gleeson FV. Steroids, radiotherapy, chemotherapy and stents for superior vena caval obstruction in carcinoma of the bronchus: a systematic review. Clin Oncol (R Coll Radiol) 2002; 14 (05) 338-351
27 Goodman R. Superior vena cava syndrome. Clinical management. JAMA 1975; 231 (01) 58-61
28 Varricchio C. Clinical management of superior vena cava syndrome. Heart Lung 1985; 14 (04) 411-416
29 Straka C, Ying J, Kong FM, Willey CD, Kaminski J, Kim DW. Review of evolving etiologies, implications and treatment strategies for the superior vena cava syndrome. Springerplus 2016; 5: 229
30 Armstrong BA, Perez CA, Simpson JR, Hederman MA. Role of irradiation in the management of superior vena cava syndrome. Int J Radiat Oncol Biol Phys 1987; 13 (04) 531-539
31 Weintraub NL, Jones WK, Manka D. Understanding radiation-induced vascular disease. J Am Coll Cardiol 2010; 55 (12) 1237-1239
32 Van Putten JW, Schlosser NJ, Vujaskovic Z, Leest AH, Groen HJ. Superior vena cava obstruction caused by radiation induced venous fibrosis. Thorax 2000; 55 (03) 245-246
33 Castonguay M, Rodrigues G, Vincent M, Malthaner RA, Guo LR. Chemoradiation-induced superior vena cava syndrome: a case report. Can Respir J 2008; 15 (08) 444-446
34 Charnsangavej C, Carrasco CH, Wallace S. et al. Stenosis of the vena cava: preliminary assessment of treatment with expandable metallic stents. Radiology 1986; 161 (02) 295-298
35 Azizi AH, Shafi I, Zhao M. et al. Endovascular therapy for superior vena cava syndrome: a systematic review and meta-analysis. EClinicalMedicine 2021; 37: 100970
36 Rizvi AZ, Kalra M, Bjarnason H, Bower TC, Schleck C, Gloviczki P. Benign superior vena cava syndrome: stenting is now the first line of treatment. J Vasc Surg 2008; 47 (02) 372-380
37 Klop B, Scheffer MG, McFadden E, Bracke F, van Gelder B. Treatment of pacemaker-induced superior vena cava syndrome by balloon angioplasty and stenting. Neth Heart J 2011; 19 (01) 41-46
38 Lanciego C, Rodriguez M, Rodriguez A, Carbonell MA, García LG. Permanent pacemaker-induced superior vena cava syndrome: successful treatment by endovascular stent. Cardiovasc Intervent Radiol 2003; 26 (06) 576-579
39 Riley RF, Petersen SE, Ferguson JD, Bashir Y. Managing superior vena cava syndrome as a complication of pacemaker implantation: a pooled analysis of clinical practice. Pacing Clin Electrophysiol 2010; 33 (04) 420-425
40 Guimaraes M, Schonholz C, Hannegan C, Anderson MB, Shi J, Selby Jr B. Radiofrequency wire for the recanalization of central vein occlusions that have failed conventional endovascular techniques. J Vasc Interv Radiol 2012; 23 (08) 1016-1021
41 Dinkel HP, Mettke B, Schmid F, Baumgartner I, Triller J, Do DD. Endovascular treatment of malignant superior vena cava syndrome: is bilateral wallstent placement superior to unilateral placement?. J Endovasc Ther 2003; 10 (04) 788-797
42 Gwon DI, Ko GY, Kim JH, Shin JH, Yoon HK, Sung KB. Malignant superior vena cava syndrome: a comparative cohort study of treatment with covered stents versus uncovered stents. Radiology 2013; 266 (03) 979-987
43 Rösch J, Uchida BT, Hall LD. et al. Gianturco-Rösch expandable Z-stents in the treatment of superior vena cava syndrome. Cardiovasc Intervent Radiol 1992; 15 (05) 319-327
44 L McDevitt J, T Goldman D, J Bundy J, et al. Gianturco Z-stent placement for the treatment of chronic central venous occlusive disease: implantation of 208 stents in 137 symptomatic patients. Diagn Interv Radiol 2021; 27 (01) 72-78
45 Gaines PA, Belli AM, Anderson PB, McBride K, Hemingway AP. Superior vena caval obstruction managed by the Gianturco Z Stent. Clin Radiol 1994; 49 (03) 202-206 , discussion 207–208
46 Han TM, Bondarev S, Keller EJ, Vogelzang RL, Resnick SA. Efficacy of endovascular Z-configuration stenting for malignant versus nonmalignant caval obstruction. J Vasc Surg Venous Lymphat Disord 2020; 8 (06) 939-944
47 Lanciego C, Pangua C, Chacón JI. et al. Endovascular stenting as the first step in the overall management of malignant superior vena cava syndrome. AJR Am J Roentgenol 2009; 193 (02) 549-558
48 Hennequin LM, Fade O, Fays JG. et al. Superior vena cava stent placement: results with the wallstent endoprosthesis. Radiology 1995; 196 (02) 353-361
49 Verstandig AG, Bloom AI, Sasson T, Haviv YS, Rubinger D. Shortening and migration of wallstents after stenting of central venous stenoses in hemodialysis patients. Cardiovasc Intervent Radiol 2003; 26 (01) 58-64
50 Fagedet D, Thony F, Timsit JF. et al. Endovascular treatment of malignant superior vena cava syndrome: results and predictive factors of clinical efficacy. Cardiovasc Intervent Radiol 2013; 36 (01) 140-149
51 Da Ines D, Chabrot P, Motreff P. et al. Cardiac tamponade after malignant superior vena cava stenting: two case reports and brief review of the literature. Acta Radiol 2010; 51 (03) 256-259
52 Vijayvergiya R, Kanabar K, Kaushal S, Lal A, Krishnan S. Endovascular treatment of a migrated superior vena cava stent in the right atrium. J Invasive Cardiol 2020; 32 (06) E168-E169
53 Taylor JD, Lehmann ED, Belli AM. et al. Strategies for the management of SVC stent migration into the right atrium. Cardiovasc Intervent Radiol 2007; 30 (05) 1003-1009
54 Srinathan S, McCafferty I, Wilson I. Radiological management of superior vena caval stent migration and infection. Cardiovasc Intervent Radiol 2005; 28 (01) 127-130
55 Okamoto D, Takeuchi Y, Arai Y. et al. Bridging stent placement through the superior vena cava to the inferior vena cava in a patient with malignant superior vena cava syndrome and an iodinated contrast material allergy. Jpn J Radiol 2014; 32 (08) 496-499
56 Haddad MM, Thompson SM, McPhail IR. et al. Is long-term anticoagulation required after stent placement for benign superior vena cava syndrome?. J Vasc Interv Radiol 2018; 29 (12) 1741-1747
57 Thony F, Fagedet D, Michoud M, Moro-Sibilot D, Ferretti GR, Rodière M. Anticoagulation is not mandatory after stenting for malignant superior vena cava syndrome. Cardiovasc Intervent Radiol 2014; 37 (05) 1403-1404
58 Uberoi R. Quality assurance guidelines for superior vena cava stenting in malignant disease. Cardiovasc Intervent Radiol 2006; 29 (03) 319-322
59 Leon D, Rao S, Huang S. et al. Literature review of percutaneous stenting for palliative treatment of malignant superior vena cava syndrome (SVCS). Acad Radiol 2021
60 Majumdar S, Shoela R, Kim DJ. et al. Endovascular management of SVC syndrome due to fibrosing mediastinitis - a feasibility and safety analysis. Vasc Endovascular Surg 2018; 52 (03) 202-206
61 Kang CH, Yang SB, Lee WH. et al. Comparison of open-cell stent and closed-cell stent for treatment of central vein stenosis or occlusion in hemodialysis patients. Iran J Radiol 2016; 13 (04) e37994
62 Smayra T, Otal P, Chabbert V. et al. Long-term results of endovascular stent placement in the superior caval venous system. Cardiovasc Intervent Radiol 2001; 24 (06) 388-394
63 Nguyen NP, Borok TL, Welsh J, Vinh-Hung V. Safety and effectiveness of vascular endoprosthesis for malignant superior vena cava syndrome. Thorax 2009; 64 (02) 174-178
64 Sobrinho G, Aguiar P. Stent placement for the treatment of malignant superior vena cava syndrome - a single-center series of 56 patients. Arch Bronconeumol 2014; 50 (04) 135-140
65 Skovira V, Ahmed M, Genese TO. Superior vena cava syndrome in conjunction with pulmonary vasculature compromise: a case study and literature review. Am J Case Rep 2018; 19: 1237-1240
66 Kishi K, Sonomura T, Mitsuzane K. et al. Self-expandable metallic stent therapy for superior vena cava syndrome: clinical observations. Radiology 1993; 189 (02) 531-535
67 Slonim SM, Dake MD, Razavi MK. et al. Management of misplaced or migrated endovascular stents. J Vasc Interv Radiol 1999; 10 (07) 851-859
68 Haddad MM, Simmons B, McPhail IR. et al. Comparison of covered versus uncovered stents for benign superior vena cava (SVC) obstruction. Cardiovasc Intervent Radiol 2018; 41 (05) 712-717
69 Cho Y, Gwon DI, Ko GY. et al. Covered stent placement for the treatment of malignant superior vena cava syndrome: is unilateral covered stenting safe and effective?. Korean J Radiol 2014; 15 (01) 87-94